Hormonal Contraceptives: Part II- Use and Relevance in Clinical Dermatology.

Area of Science:

• Dermatology
• Endocrinology
• Pharmacology

Background:

• Combined oral contraceptives (COCs) reduce androgen levels by inhibiting production and increasing sex hormone-binding globulin.
• COCs can be utilized for treating androgen-mediated dermatologic conditions.
• Hormonal contraceptives may also influence dermatologic conditions via estrogen and progesterone receptor interactions.

Purpose of the Study:

• To discuss the mechanism and efficacy of hormonal contraceptives in treating acne, hirsutism, and hair loss.
• To review potential dermatologic side effects of hormonal contraceptives.
• To guide dermatologists in the clinical application of hormonal contraceptives.

Main Methods:

• Review of existing evidence on hormonal contraceptive mechanisms.
• Analysis of clinical studies on the efficacy of COCs for specific dermatologic conditions.
• Evaluation of reported dermatologic side effects associated with hormonal contraceptive use.

Main Results:

• COCs demonstrate efficacy in managing acne, hirsutism, and hair loss by modulating androgen levels.
• Understanding receptor interactions is crucial for predicting and managing potential dermatologic side effects.
• Evidence supports the therapeutic role of COCs in specific androgen-dependent dermatoses.

Conclusions:

• Hormonal contraceptives, particularly COCs, offer a viable therapeutic option for several androgen-mediated dermatologic conditions.
• Dermatologists should be aware of both the benefits and potential adverse dermatologic effects of these agents.
• Further research may refine the use of hormonal contraceptives for optimizing dermatologic outcomes.